748 related articles for article (PubMed ID: 17448867)
41. Cholecystitis induced by Yttrium-90 radioembolization of advanced liver tumors: prospective evaluation of a management algorithm in 197 consecutive patients.
Damm R; Bregenzer C; Steffen I; Amthauer H; Seidensticker R; Seidensticker M; Omari J; Ricke J; Pech M
Acta Radiol; 2023 Oct; 64(10):2783-2790. PubMed ID: 37525508
[TBL] [Abstract][Full Text] [Related]
42. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.
Dezarn WA; Cessna JT; DeWerd LA; Feng W; Gates VL; Halama J; Kennedy AS; Nag S; Sarfaraz M; Sehgal V; Selwyn R; Stabin MG; Thomadsen BR; Williams LE; Salem R;
Med Phys; 2011 Aug; 38(8):4824-45. PubMed ID: 21928655
[TBL] [Abstract][Full Text] [Related]
43. Radioembolization for hepatocellular carcinoma using TheraSphere®.
Ali SM
Saudi J Gastroenterol; 2011; 17(3):215-7. PubMed ID: 21546728
[TBL] [Abstract][Full Text] [Related]
44. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS
Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878
[TBL] [Abstract][Full Text] [Related]
45. Radioembolization for hepatocellular carcinoma.
Sangro B; Iñarrairaegui M; Bilbao JI
J Hepatol; 2012 Feb; 56(2):464-73. PubMed ID: 21816126
[TBL] [Abstract][Full Text] [Related]
46. Technical aspects of radioembolization with 90Y microspheres.
Salem R; Lewandowski RJ; Sato KT; Atassi B; Ryu RK; Ibrahim S; Nemcek AA; Omary RA; Madoff DC; Murthy R
Tech Vasc Interv Radiol; 2007 Mar; 10(1):12-29. PubMed ID: 17980315
[TBL] [Abstract][Full Text] [Related]
47. Red Flags, Pitfalls, and Cautions in Y90 Radiotherapy.
Klimkowski S; Baker JC; Brown DB
Tech Vasc Interv Radiol; 2019 Jun; 22(2):63-69. PubMed ID: 31079712
[TBL] [Abstract][Full Text] [Related]
48. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
49. Microsphere radioembolization of liver malignancies: current developments.
Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312
[TBL] [Abstract][Full Text] [Related]
50. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
[TBL] [Abstract][Full Text] [Related]
51. Management of High Hepatopulmonary Shunts in the Setting of Y90 Radioembolization.
Schiro BJ; Amour ES; Harnain C; Gandhi RT
Tech Vasc Interv Radiol; 2019 Jun; 22(2):58-62. PubMed ID: 31079711
[TBL] [Abstract][Full Text] [Related]
52. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429
[TBL] [Abstract][Full Text] [Related]
53. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.
Saxena A; Kapoor J; Meteling B; Morris DL; Bester L
Ann Surg Oncol; 2014 Apr; 21(4):1296-303. PubMed ID: 24337647
[TBL] [Abstract][Full Text] [Related]
54. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
Pasciak AS; Bourgeois AC; Bradley YC
J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
[TBL] [Abstract][Full Text] [Related]
55. Technical Aspects and Practical Approach Toward Same-Day Y90 Radioembolization in the Management of Hepatocellular Carcinoma.
Gabr A; Ali R; Al Asadi A; Mora R; Mouli S; Riaz A; Salem R; Lewandowski RJ
Tech Vasc Interv Radiol; 2019 Jun; 22(2):93-99. PubMed ID: 31079717
[TBL] [Abstract][Full Text] [Related]
56. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
Atassi B; Bangash AK; Lewandowski RJ; Ibrahim S; Kulik L; Mulcahy MF; Murthy R; Ryu RK; Sato KT; Miller FH; Omary RA; Salem R
J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
[TBL] [Abstract][Full Text] [Related]
57. ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies.
Hong K; Akinwande O; Bodei L; Chamarthy MR; Devlin PM; Elman S; Ganguli S; Kennedy AS; Koo SJ; Ouhib Z; Padia SA; Salem R; Selwyn RG; Yashar CM; Yoo DC; Zaki BI; Hartford AC; Trimmer CK
Brachytherapy; 2021; 20(3):497-511. PubMed ID: 33824051
[TBL] [Abstract][Full Text] [Related]
58. Radioembolization of liver tumors with yttrium-90 microspheres.
Ahmadzadehfar H; Biersack HJ; Ezziddin S
Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679
[TBL] [Abstract][Full Text] [Related]
59. Radioembolization with yttrium-90 microspheres work up: Practical approach and literature review.
Vesselle G; Petit I; Boucebci S; Rocher T; Velasco S; Tasu JP
Diagn Interv Imaging; 2015 Jun; 96(6):547-62. PubMed ID: 24776810
[TBL] [Abstract][Full Text] [Related]
60. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
Salem R; Hunter RD
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
